Epidermal Growth Factor Receptor (EGFR)–Retargeted Measles Virus Strains Effectively Target EGFR- or EGFRvIII Expressing Gliomas

Autor: Georgia Paraskevakou, Mark A. Schroeder, Takafumi Nakamura, Kah Whye Peng, Paula J. Zollman, C. David James, Evanthia Galanis, Cory Allen, Stephen J. Russell
Rok vydání: 2007
Předmět:
viruses
Gene Expression
Mice
0302 clinical medicine
Signaling Lymphocytic Activation Molecule Family Member 1
Cricetinae
Chlorocebus aethiops
Drug Discovery
Epidermal growth factor receptor
Mice
Inbred BALB C

0303 health sciences
Chinese hamster ovary cell
Glioma
Recombinant Proteins
3. Good health
ErbB Receptors
030220 oncology & carcinogenesis
Molecular Medicine
Genetic Engineering
Green Fluorescent Proteins
Transplantation
Heterologous

Mice
Nude

Receptors
Cell Surface

CHO Cells
Biology
Virus
Membrane Cofactor Protein
Measles virus
03 medical and health sciences
Cricetulus
Antigens
CD

Cell Line
Tumor

medicine
Genetics
Animals
Humans
Virotherapy
Vero Cells
Molecular Biology
030304 developmental biology
Pharmacology
CD46
Genes
erbB-1

Genetic Therapy
medicine.disease
biology.organism_classification
Molecular biology
Transplantation
Mutation
biology.protein
Neoplasm Transplantation
Zdroj: Molecular Therapy. 15(4):677-686
ISSN: 1525-0016
DOI: 10.1038/sj.mt.6300105
Popis: A retargeted measles virus strain MV-GFP-H(AA)-scEGFR was generated by engineering the MV-NSe Edmonston vaccine strain to incorporate both CD46 (Y481A) and signaling lymphocyte activation molecule (SLAM) (R533A) ablating mutations in the hemagglutinin protein in combination with the display of a single-chain antibody against epidermal growth factor receptor (EGFR) at the C terminus of hemagglutinin. The unmodified MV-GFP virus was used as a positive control. Specificity of the EGFR retargeted virus was demonstrated in non-permissive Chinese hamster ovary (CHO) cells stably transfected to express either the natural receptors CD46 or SLAM or the target receptors EGFR and EGFRvIII. In vitro, the retargeted virus had potent antitumor activity against EGFR- or EGFRvIII-overexpressing primary glioblastoma multi-forme (GBM) cell lines that was comparable to the activity of the unmodified MV-GFP virus. Intratumoral administration of MV-GFP-H(AA)-scEGFRvIII in orthotopic GBM12 xenografts resulted in tumor regression, as demonstrated by bioluminescence imaging and significant prolongation of survival, that was comparable to the effect of the unmodified strain. In contrast to MV-GFP, central nervous system administration of the targeted MV-GFP-H(AA)-scEGFR virus in measles replication-permissive Ifnar(ko) CD46 transgenic mice resulted in no neurotoxicity. In conclusion, EGFR-retargeted measles virus strains have comparable therapeutic efficacy to the unmodified virus in glioma cells overexpressing EGFR or EGFRvIII in vivo and in vitro, and improved therapeutic index, a finding with potential translational implications in glioma virotherapy.
Databáze: OpenAIRE